Research: Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
16 Feb, 2018 | 01:34h | UTC“Apalutamide improves castration resistant prostate CA survival compared with… placebo. Why wasn’t it compared w bicalutamide?” (via @RichardLehman1 see Tweet). See Richard Lehman’s point of view